Physician profile
Todd M Dewey
NPI 1891783403
$128,024.02
in general payments reported to CMS, 2019-2025
15 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $14K · 2021: $13K · 2022: $31K · 2023: $30K · 2024: $8,319 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $23K · Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,900 · Food and Beverage: $4,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $22,888.34 |
| Consulting Fee | $13,725.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,900.00 |
| Food and Beverage | $4,399.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $102,545.03 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $11,973.48 | 2021-2025 | Corevalve Evolut R, Cg Future, Avalus |
| Abbott Laboratories | $11,279.00 | 2019-2025 | Epic, Navitor, Portico |
| Atricure, INC. | $1,082.17 | 2019-2025 | Synergy Ablation System |
| Kls-Martin L.P. | $336.20 | 2020-2025 | |
| Medtronic Vascular, INC. | $236.98 | 2019-2020 | |
| Angiodynamics, INC. | $217.19 | 2021 | |
| Abiomed | $135.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.59 | 2022 | |
| Biomerieux INC | $44.52 | 2019 | |
| Smith+Nephew, INC. | $32.32 | 2019 | |
| Stryker Corporation | $31.47 | 2024 | Na |
| Baxter Healthcare | $30.28 | 2021-2024 | Floseal |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Dewey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.